These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 9261744

  • 1. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features.
    Knoll MR, Schwab M, Oestreich K, Rumstadt B, Hagmüller E.
    J Exp Clin Cancer Res; 1997 Jun; 16(2):177-82. PubMed ID: 9261744
    [Abstract] [Full Text] [Related]

  • 2. Differences in tumor cell proliferation, HLA DR expression and lymphocytic infiltration in various types of thyroid carcinoma.
    Lindhorst E, Schumm-Draeger PM, Bojunga J, Usadel KH, Herrmann G.
    Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):27-31. PubMed ID: 11835122
    [Abstract] [Full Text] [Related]

  • 3. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG, Munoz IM, Nooyen Y, Fleuren GJ.
    Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
    [Abstract] [Full Text] [Related]

  • 4. Galectin-3 expression in papillary thyroid carcinoma: relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size.
    Cvejic DS, Savin SB, Petrovic IM, Paunovic IR, Tatic SB, Havelka MJ.
    Head Neck; 2005 Dec; 27(12):1049-55. PubMed ID: 16155918
    [Abstract] [Full Text] [Related]

  • 5. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X, Quiros RM, Maxhimer JB, Jiang P, Marcinek R, Ain KB, Platt JL, Shen J, Gattuso P, Prinz RA.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [Abstract] [Full Text] [Related]

  • 6. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
    Chang HY, Lin JD, Chou SC, Chao TC, Hsueh C.
    Jpn J Clin Oncol; 2006 Nov 01; 36(11):688-93. PubMed ID: 17000702
    [Abstract] [Full Text] [Related]

  • 7. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M, Ghossein RA, Schoder H, Gomez D, Larson SM, Tuttle RM.
    Cancer; 2008 Jul 01; 113(1):48-56. PubMed ID: 18484584
    [Abstract] [Full Text] [Related]

  • 8. Expression and function of the chemokine receptor CCR7 in thyroid carcinomas.
    Sancho M, Vieira JM, Casalou C, Mesquita M, Pereira T, Cavaco BM, Dias S, Leite V.
    J Endocrinol; 2006 Oct 01; 191(1):229-38. PubMed ID: 17065406
    [Abstract] [Full Text] [Related]

  • 9. Lymphocytic infiltration in pediatric thyroid carcinomas.
    Van Savell H, Hughes SM, Bower C, Parham DM.
    Pediatr Dev Pathol; 2004 Oct 01; 7(5):487-92. PubMed ID: 15547772
    [Abstract] [Full Text] [Related]

  • 10. [Immunohistochemical studies of mononuclear cellular infiltrates of papillary, follicular and anaplastic thyroid cancers].
    Kornfehl J, Wilfing A, Hermann M.
    Laryngorhinootologie; 1994 Apr 01; 73(4):183-8. PubMed ID: 8011021
    [Abstract] [Full Text] [Related]

  • 11. Reciprocal immunohistochemical expression of sodium/iodide symporter and hexokinase I in primary thyroid tumors with synchronous cervical metastasis.
    Jung YH, Hah JH, Sung MW, Kim KH, Cho SY, Jeon YK.
    Laryngoscope; 2009 Mar 01; 119(3):541-8. PubMed ID: 19235753
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC, Bedard YC, Rosen IB.
    J Am Coll Surg; 2004 Mar 01; 198(3):341-8. PubMed ID: 14992733
    [Abstract] [Full Text] [Related]

  • 13. Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma.
    Ryschich E, Nötzel T, Hinz U, Autschbach F, Ferguson J, Simon I, Weitz J, Fröhlich B, Klar E, Büchler MW, Schmidt J.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):498-504. PubMed ID: 15701833
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.
    Kamoshida S, Ogane N, Yasuda M, Muramatsu T, Bessho T, Kajiwara H, Osamura RY.
    Mod Pathol; 2000 Jul 15; 13(7):736-41. PubMed ID: 10912932
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM, Adabi Kh, Lashkari A, Heshmat R, Haghpanah V, Larijani B, Tavangar SM.
    Pathol Res Pract; 2009 Jul 15; 205(2):83-7. PubMed ID: 18996649
    [Abstract] [Full Text] [Related]

  • 16. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G, Tallini G, De Biasio MC, Manfioletti G, Martinez-Tello FJ, Pentimalli F, de Nigris F, Mastro A, Botti G, Fedele M, Berger N, Santoro M, Giancotti V, Fusco A.
    Cancer Res; 1998 Sep 15; 58(18):4193-8. PubMed ID: 9751634
    [Abstract] [Full Text] [Related]

  • 17. Regional metastases in well-differentiated thyroid carcinoma: pattern of spread.
    Yanir Y, Doweck I.
    Laryngoscope; 2008 Mar 15; 118(3):433-6. PubMed ID: 18043490
    [Abstract] [Full Text] [Related]

  • 18. Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma.
    Koperek O, Scheuba C, Puri C, Birner P, Haslinger C, Rettig W, Niederle B, Kaserer K, Garin Chesa P.
    Int J Oncol; 2007 Jul 15; 31(1):59-67. PubMed ID: 17549405
    [Abstract] [Full Text] [Related]

  • 19. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M.
    Hum Pathol; 2008 Nov 15; 39(11):1656-63. PubMed ID: 18657294
    [Abstract] [Full Text] [Related]

  • 20. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
    Redondo M, Concha A, Oldiviela R, Cueto A, Gonzalez A, Garrido F, Ruiz-Cabello F.
    Cancer Res; 1991 Sep 15; 51(18):4948-54. PubMed ID: 1654207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.